- CA$568.09m
- CA$747.45m
- $289.28m
- 61
- 56
- 66
- 64
Annual income statement for 5N Plus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 177 | 210 | 264 | 242 | 289 |
| Cost of Revenue | |||||
| Gross Profit | 36.4 | 38.8 | 48.5 | 57.5 | 77.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 164 | 197 | 277 | 215 | 257 |
| Operating Profit | 13.5 | 12.9 | -13.1 | 27.4 | 32.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 7.21 | 8.74 | -18.3 | 18.7 | 23.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2.19 | 3.11 | -23 | 15.4 | 14.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 2.19 | 3.11 | -23 | 15.4 | 14.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 2.19 | 3.11 | -23 | 15.4 | 14.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.021 | 0.056 | -0.141 | 0.111 | 0.18 |